期刊文献+

粪便钙卫蛋白在克罗恩病活动度判断中的诊断效能 被引量:4

Diagnostic efficacy of fecal calprotectin on assessing crohn′s disease activity
下载PDF
导出
摘要 目的研究粪便钙卫蛋白(FC)在结肠或回结肠型克罗恩病(CD)及CD术后患者内镜下活动度判断中的诊断效能。方法选取已确诊结肠或回结肠型CD患者56例、CD术后患者25倒及肠易激综合征(IBS)患者25例。均于结肠镜检查前1~3d内留取粪便,采用ELISA方法测定FC的水平。结肠或回结肠型CD及CD术后患者内镜活动度评估分剐采用简单克罗恩病内镜评分(SES-CD)和Rutgeerts’评分。结果在结肠或回结肠型CD患者中,活动期FC水平明显高于缓解期和IBS组(P〈0.01),FC水平与SES-CD评分呈正相关(r=0.802,P〈0.01),FC在临界值250μg/g时预测内镜活动度的灵敏度和特异度分别为97.1%和71.4%。在CD术后患者中,活动期及缓解期FC水平均明显高于IBS组(P〈0.01),但活动期FC水平与缓解期相比差异无统计学意义(P〉0.05),FC在临界值250μg/g时预测内镜疾病复发的灵敏度和特异度分别为50.0%和66.7%。结论FC能准确地反映结肠或回结肠型CD患者内镜疾病的活动度,但FC不能区别CD术后患者疾病的缓解期和活动期。 Objective To investigate the diagnostic efficacy of fecal calprotectin(FC) on assessing endoscopic disease activity in colonic or ileo-colonic Crohn disease (CD) and CD-related surgery patients. Methods Totally 56 colonic or ileo-eolonie CD patients, 25 CD-related surgery patients and 25 irritable bowel syndrome (IBS) patients with previously confirmed diagnosis of CD and IBS were enrolled into this study. Fecal samples were collected from 1 to 3 clay before bowel preparation and FC was measured by ELISA. Endoscopic activity was determined for colonic or ileo-eolonic CD with Simple Endoscopic Score for Crohnts Disease (SES- CD) and CD-related surgery patients with the Rutgeerts' score. Results Among colonic or ileo-colonic CD patients, the levels of FC in endoscopic active patients had significantly higher than that of endoscopic remission patients and IBS patients(P〈0. 01), there was significant correlation between levels of FC and the SES-CD (r=0. 802 ,P〈0.01). FC threshold of 250μg/g was tested to indicated active endoscopic disease with 97.1% sensitivity and 71.4% specificity. Among CD-related surgery patients,FC level in IBS patients were significantly lower than that of endoscopic remission patients and endoscopic active patients, but the FC in endoscopie remission patients and endoscopic active patients had no statistic difference(P〈0.05), FC cutoff level of 250 μg/g gave a sensitivity and specificity of 50.0 %, 66.7 %, respectively. Conclusion FC is a surrogate marker for the evaluation of colonic or iteo-colonic CD endoscopic disease activity. The FC, however, can not distinct remission period and active period after CD surgery.
出处 《重庆医学》 CAS 北大核心 2016年第2期209-211,215,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(81472320)
关键词 钙卫蛋白 CROHN病 内窥镜检查 calprotectin Crohn disease endoscopy
  • 相关文献

参考文献16

  • 1Xavier R J, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease[J]. Nature, 2007,448 (7152 ) : 427-434. 被引量:1
  • 2Zhao J, Ng SC, Lei Y, et al. First prospective, population- based inflammatory bowel disease incidence study in ma- inland of China: the emergence Of "western" disease[J]. Inflamm Bowel Dis,2013,19(9):1839-1845. 被引量:1
  • 3Zeng Z,Zhu Z,Yang Y,et al. Incidence and clinical char- acteristics of inflammatory bowel disease in a developed region of Guangdong province,China:a prospective popu- lation-based study[J]. J Gastroenterol Hepatol, 2013,28 (7) : 1148-1153. 被引量:1
  • 4Benitez JM, Meuwis MA, Reenaers C, et al. Role of endos- copy,cross-sectional imaging and biomarkers in CrohnPs disease monitoring[J]. Gut,2013,62(12) :1806-1816. 被引量:1
  • 5Summerton CB, Longlands MG, Wiener K, et al. Faecal calprotectin:a marker of inflammation throughout the in- testinal tract[J]. Eur J Gastroenterol Hepatol, 2002, 14 (8) :841-845. 被引量:1
  • 6刘文斌,吕愈敏,杨雪玲,金珠.粪便钙卫蛋白对溃疡性结肠炎活动性判断价值的研究[J].中华消化杂志,2005,25(7):394-397. 被引量:19
  • 7白青山,韩明子,金世柱.粪便钙卫蛋白在溃疡性结肠炎诊断中的作用价值[J].胃肠病学和肝病学杂志,2012,21(7):676-678. 被引量:7
  • 8Daperno M, D' haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohnr s disease: the SES-CD[J]. Gastrointest Endosc, 2004,60(4) : 505-512. 被引量:1
  • 9Scarpa M, DIincd R, Basso D, et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohnrs disease [J]. Dis Colon Rectum,2007,50(6) :861-869. 被引量:1
  • 10Sipponen T,Savilahti E,Kolho KL, et al. Crohnrs disease activity assessed by fecal calprotectin and lactoferrin:cor- relation with Crohns disease activity index and endoscop- ic findings[J]. Inflamm Bowel Dis, 2008,14(1) : 40-46. 被引量:1

二级参考文献28

  • 1刘文斌,吕愈敏,杨雪玲,金珠.粪便钙卫蛋白对溃疡性结肠炎活动性判断价值的研究[J].中华消化杂志,2005,25(7):394-397. 被引量:19
  • 2Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol, 1980,24:393-398. 被引量:1
  • 3Fagerhol MK. Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein? Mol Pathol, 1996, 49(suppl): M74-M79. 被引量:1
  • 4Johne B, Fagerhol MK, Lyberg T, et al, Functional and clinical aspects of the myelomonocyte protein calprotectin, Mol Pathol, 1997, 50:113-123. 被引量:1
  • 5Kerkhoffc, Klempt M, Sorg C. Novel insights into structure and function of MRP8 and MRP 14. Biochim Biophys Acta,1998,1448: 200-211. 被引量:1
  • 6Roseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion. 1997, 58: 176-180. 被引量:1
  • 7Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol, 1999,34: 50-54. 被引量:1
  • 8Bunn SK, Bisset WM, Main M J, et al. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 2001, 32:171-177. 被引量:1
  • 9Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol, 1992, 27:793-798. 被引量:1
  • 10Shine B, Berghouse L, Jones JE, et al. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta, 1985, 148:105-109. 被引量:1

共引文献23

同被引文献21

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部